As breast conserving surgery increases in the surgical treatment of breast cancer, partial mastectomy is also increasing. Polycaprolactone (PCL) is a polymer that is used as an artifact in various parts of the human body based on the biocompatibility and mechanical properties of PCL. Here, we hypothesized that a PCL scaffold can be utilized for the restoration of breast tissue after a partial mastectomy. To demonstrate the hypothesis, a PCL scaffold was fabricated by 3D printing and three types of spherical PCL scaffold including PCL scaffold, PCL scaffold with collagen, and the PCL scaffold with breast tissue fragment were implanted in the rat breast defect model. After 6 months of implantation, the restoration of breast tissue was observed in the PCL scaffold and the expression of collagen in the PCL scaffold with collagen was seen. The expression of TNF-α was significantly increased in the PCL scaffold, but the expression of IL-6 showed no significant difference in all groups. Through this, it showed the possibility of using it as a method to conveniently repair tissue defects after partial mastectomy of the human body.
Growing evidence has demonstrated that biomimetic nanovesicles produced from specific cells show bioactive properties such as anti-tumor or anti-inflammatory activities. However, the properties of these nanovesicles are very diverse, depending on their cell sources. In this study, human tonsil-derived mesenchymal stem cells (TMSCs) were used in the production of functional biomimetic nanovesicles with anti-senescence. TMSCs were isolated from human tonsil tissue obtained by tonsillectomy. TMSC-derived nanovesicles (TMSC-NVs) were produced by serial extrusion using a mini-extruder. Western blotting and particle analysis were performed for characterization of TMSC-NVs. They were applied to both replicative and ultraviolet B-induced senescent human dermal fibroblasts in vitro. Following six days of treatment, analysis of the proliferation and senescence level of fibroblasts was performed using cell counting and senescence-associated β-galactosidase assay, respectively. Treatment with TMSC-NVs enhanced the cell proliferation and reduced the activity of senescence-associated β-galactosidase in both replicative and ultraviolet B-induced senescent cells. Treatment with TMSC-NVs resulted in increased expression of extracellular matrix and anti-oxidant genes. Treatment with TMSC-NVs resulted in reduced expression of vinculin in focal adhesion. These results show that TMSC-NVs have an effect on recovering from cellular senescence by oxidative stress and can be applied as useful materials for the development of skin rejuvenation.
Autologous skin grafting is considered the standard treatment for full-thickness skin defects and provides essential dermal reconstruction to support both functional and aesthetic skin outcomes. However, it has limitations, such as increased donor-site morbidity, suboptimal aesthetic outcomes, thickness mismatches, texture irregularities, and scar contractions. Several dermal substitutes have been developed to overcome these limitations. In the present study, we introduce TissueDerm Graft®, a novel collagen-based dermal substitute designed to improve both functional and aesthetic outcomes in skin grafting by providing a regular structure that supports dermal tissue regeneration. We compared the properties and efficacy of TissueDerm Graft® with those of bovine acellular dermal matrix (Matriderm®). A full-thickness skin defect was induced in minipigs and TissueDerm Graft® or Matriderm® were simultaneously transplanted with a split-thickness skin graft (STSG). In the present study, TissueDerm Graft® exhibited tightly packed and uniform collagen fibers, a consistent pore distribution, and elastin. The full-thickness skin defect model demonstrated favorable wound healing without inducing excessive inflammatory responses or excessive scar formation. Compared with the single implantation of STSG and co-implantation of STSG and Matriderm®, the co-implantation of STSG and TissueDerm Graft® improved the visual outcomes. These findings suggest that TissueDerm Graft® could serve as a promising dermal substitute for skin grafting and skin tissue regeneration.
Aging greatly contributes to the progressive dysfunction of tissues and organs that accompany the aging process. Recently, nanovesicles derived from tonsil mesenchymal stem cells (TMSC-NVs) were investigated for their potential to reverse cellular senescence. However, the molecular mechanisms through which TMSC-NVs prevent senescence remain unclear. In the present study, we focused on Cluster of Differentiation 146 (CD146), a surface marker used to identify specific MSC subgroups and examined the anti-senescence effects of CD146-positive TMSC-NVs (CD146 + TMSC-NVs). To evaluate the antisenescence effects of the CD146 + TMSC-NVs, passage-associated cellular senescence in vitro human dermal fibroblast model, ultraviolet-B-induced photoaging ex vivo model, and intrinsic aging in vivo mice model were assessed. Microarray analysis, immunofluorescence staining, and miRNA profiling demonstrated the anti-senescence mechanism of CD146 + TMSC-NVs through modulation of the p53 pathway, thereby effectively suppressing cellular senescence and matrix metalloproteinase activity and improving extracellular matrix remodeling. These results indicate the anti-senescence effects of CD146 + TMSC-NVs for therapeutic approach.